Alembic Pharmaceuticals Limited — Credit Ratings, 11-06-2026: Credit Rating
11-06-2026 | 09:52 pm
11-06-2026 | 09:52 pm
Alembic Pharmaceuticals' Commercial Paper program of Rs. 1,100.00 Cr has received a reaffirmation of its 'CARE A1+' rating from CARE Ratings Limited. This indicates continued strong credit quality, signaling stability in the company's short-term borrowing instruments. This reaffirmation is a positive for investors, reflecting consistent financial health.
No comments yet. Be the first to comment!
